Company
VistaPath
Modernizing pathology labs by delivering higher quality, efficiency, and consistency across critical lab processes
Also known as Vistapath Biosystems, Vistapath Biosystems, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Customers
- Commercial Labs Hospitals CROs Life Sciences
- Legal name
- Vistapath Biosystems, Inc.
- vistapath.ai (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Vistapath was founded to accomplish a single mission: to modernize pathology, giving pathology labs the tools they need to increase the quality, efficiency, and consistency across all critical lab processes, because when patients are involved it’s critical to get it right.
Funding snapshot
- Total raised
- $13.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4.4M2023-06-22
Funding rounds
- Round, 2023
- $4.4M2023-06-22, SEC form D sold, 5 investors
- Round, 2023
- $1M2023-01-20, SEC form D sold, 1 investor
- Round, 2022
- $7.4M2022-01-27, SEC form D sold, 35 investors
- Round, 2021
- $100K2021-05-06, SEC form D sold, 4 investors
- Round, 2020
- $470K2020-03-18, SEC form D sold, 9 investors
- Round, 2019
- $225K2019-06-24, SEC form D sold, 4 investors
Products
- Other
- Sentinel
Loading relationship preview